Review paper
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
Abstract
Traditional cancer therapy has many disadvantages such as low selectivity and high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance the cytotoxic effect and targeting ability, while reducing the toxicity of antitumor drugs, an antibody drug conjugate (ADC) was developed to deliver small molecular cytotoxic payloads directly to tumor cells by binding to specific antibodies via linkers.By reviewing...
Paper Details
Title
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
Published Date
Jun 24, 2021
Journal
Volume
10
Issue
14
Pages
4677 - 4696
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History